CMV and relapse: what has conditioning to do with it?
Asklepios Klinik Altona, Hamburg, Germany. Electronic address: A.Elmaagacli@asklepios.com.
Ahmet H
AH
Elmaagacli
D003587:Cytomegalovirus / Q000502:physiology*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D019653:Myeloablative Agonists / Q000627:therapeutic use*; D019172:Transplantation Conditioning / Q000379:methods*; D014775:Virus Activation / Q000187:drug effects*
D019653:Myeloablative Agonists